TMCnet News
Research and Markets: Global Non-Hodgkin Lymphoma Therapeutics Pipeline Review 2014 - Analysis of 82 Companies & 113 Drug ProfilesDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/gmk82g/nonhodgkin) has announced the addition of the "Non-Hodgkin Lymphoma - Pipeline Review, H1 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Non-Hodgkin Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Non-Hodgkin Lymphoma and special features on late-stage and discontinued proects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Scope
For more information visit http://www.researchandmarkets.com/research/gmk82g/nonhodgkin
|